Literature DB >> 22072701

Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study.

Martin R Turner1, Clare Wotton, Kevin Talbot, Michael J Goldacre.   

Abstract

BACKGROUND: Amyotrophic lateral sclerosis (ALS) appears to be a sporadic disorder in 95% of cases. Although few personal characteristics associated with developing ALS are known, identification of those at risk is essential to any vision of early intervention. There is persistent anecdotal observation that those with ALS are premorbidly physically 'fitter', although such observations are susceptible to bias. Hospital admission for coronary heart disease (CHD) might serve as an objective marker of reduced cardiovascular fitness.
METHODS: A record linkage study of two large databases of hospital admissions, the Oxford Record Linkage Study (ORLS) and an English national record linkage dataset of Hospital Episode Statistics was undertaken. The ratio of the rate of ALS in people without a record of CHD to that in those with a record of CHD was calculated, factoring out premature death in both cohorts. Similar analysis for Parkinson's disease (PD) and multiple sclerosis (MS) was undertaken.
RESULTS: In the English population, the rate ratio for ALS in the non-CHD cohort, compared with the CHD cohort, was 1.14 (95% CI 1.05 to 1.22); for PD it was 0.95 (95% CI 0.93 to 0.98); and for MS 0.95 (95% CI 0.88 to 1.04). The ORLS data yielded similar findings.
CONCLUSIONS: Those without a record of CHD were at modestly higher risk of ALS, but not for PD or MS. This lends support to the assertion that ALS arises within a population who may have relatively higher levels of cardiovascular fitness.

Entities:  

Mesh:

Year:  2011        PMID: 22072701     DOI: 10.1136/jnnp-2011-301161

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  23 in total

1.  Cardiovascular disease and diagnosis of amyotrophic lateral sclerosis: A population based study.

Authors:  Marianthi-Anna Kioumourtzoglou; Ryan M Seals; Ole Gredal; Murray A Mittleman; Johnni Hansen; Marc G Weisskopf
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-07-20       Impact factor: 4.092

Review 2.  Amyotrophic lateral sclerosis: cell vulnerability or system vulnerability?

Authors:  Kevin Talbot
Journal:  J Anat       Date:  2013-09-08       Impact factor: 2.610

Review 3.  Defining pre-symptomatic amyotrophic lateral sclerosis.

Authors:  Michael Benatar; Martin R Turner; Joanne Wuu
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-03-20       Impact factor: 4.092

Review 4.  Epidemiological evidence that physical activity is not a risk factor for ALS.

Authors:  Bello Hamidou; Philippe Couratier; Cyril Besançon; Marie Nicol; Pierre Marie Preux; Benoit Marin
Journal:  Eur J Epidemiol       Date:  2014-07-02       Impact factor: 8.082

5.  Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Theodore Hyman; Amy Shui; Peggy Allred; Matthew Harms; Jingxia Liu; Nicholas Maragakis; David Schoenfeld; Hong Yu; Nazem Atassi; Merit Cudkowicz; Timothy M Miller
Journal:  Muscle Nerve       Date:  2015-06-01       Impact factor: 3.217

6.  Prior medical conditions and the risk of amyotrophic lateral sclerosis.

Authors:  Meinie Seelen; Perry T C van Doormaal; Anne E Visser; Mark H B Huisman; Margot H J Roozekrans; Sonja W de Jong; Anneke J van der Kooi; Marianne de Visser; Nicol C Voermans; Jan H Veldink; Leonard H van den Berg
Journal:  J Neurol       Date:  2014-07-25       Impact factor: 4.849

Review 7.  Motor neuron disease: biomarker development for an expanding cerebral syndrome.

Authors:  Martin R Turner
Journal:  Clin Med (Lond)       Date:  2016-12       Impact factor: 2.659

8.  Premorbid body mass index and risk of amyotrophic lateral sclerosis.

Authors:  Éilis J O'Reilly; Hao Wang; Marc G Weisskopf; Kathryn C Fitzgerald; Guido Falcone; Marjorie L McCullough; Michael Thun; Yikyung Park; Laurence N Kolonel; Alberto Ascherio
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2012-10-29       Impact factor: 4.092

9.  Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study.

Authors:  Martin R Turner; Raph Goldacre; Sreeram Ramagopalan; Kevin Talbot; Michael J Goldacre
Journal:  Neurology       Date:  2013-08-14       Impact factor: 9.910

10.  Pre-diagnostic plasma lipid levels and the risk of amyotrophic lateral sclerosis.

Authors:  Kjetil Bjornevik; Éilis J O'Reilly; Marianna Cortese; Jeremy D Furtado; Laurence N Kolonel; Loic Le Marchand; Marjorie L Mccullough; Sabrina Paganoni; Michael A Schwarzschild; Aladdin H Shadyab; Joann E Manson; Alberto Ascherio
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2020-09-28       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.